Pub Date : 2024-02-28DOI: 10.1007/s13629-024-00421-9
Melianthe P. J. Nicolai
{"title":"Sexual health and androgen deprivation therapy in prostate cancer—a narrative review","authors":"Melianthe P. J. Nicolai","doi":"10.1007/s13629-024-00421-9","DOIUrl":"https://doi.org/10.1007/s13629-024-00421-9","url":null,"abstract":"","PeriodicalId":38523,"journal":{"name":"Tijdschrift voor Urologie","volume":"135 18","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140423147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-28DOI: 10.1007/s13629-024-00420-w
Rosemarijn H. Ettema, Wietske I. Luining, A. N. Vis, Roderick C. N. van den Bergh
{"title":"PSMA PET/CT in diagnostiek en responsevaluatie in patiënten met primair gemetastaseerd prostaatkanker","authors":"Rosemarijn H. Ettema, Wietske I. Luining, A. N. Vis, Roderick C. N. van den Bergh","doi":"10.1007/s13629-024-00420-w","DOIUrl":"https://doi.org/10.1007/s13629-024-00420-w","url":null,"abstract":"","PeriodicalId":38523,"journal":{"name":"Tijdschrift voor Urologie","volume":"29 24","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140419070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-28DOI: 10.1007/s13629-024-00418-4
Jean-Paul van Basten, Inge van Oort
{"title":"Voorwoord bij het themanummer ‘Systeemtherapie voor prostaatkanker’","authors":"Jean-Paul van Basten, Inge van Oort","doi":"10.1007/s13629-024-00418-4","DOIUrl":"https://doi.org/10.1007/s13629-024-00418-4","url":null,"abstract":"","PeriodicalId":38523,"journal":{"name":"Tijdschrift voor Urologie","volume":"32 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140418785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-28DOI: 10.1007/s13629-024-00422-8
Jorg R. Oddens, Marsha van Oostwaard
{"title":"Hormoontherapie voor prostaatkanker: gevolgen voor de botgezondheid","authors":"Jorg R. Oddens, Marsha van Oostwaard","doi":"10.1007/s13629-024-00422-8","DOIUrl":"https://doi.org/10.1007/s13629-024-00422-8","url":null,"abstract":"","PeriodicalId":38523,"journal":{"name":"Tijdschrift voor Urologie","volume":"11 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140419116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-28DOI: 10.1007/s13629-024-00419-3
Jean-Paul van Basten, Inge van Oort
{"title":"New developments in the treatment of metastatic hormone-sensitive prostate cancer","authors":"Jean-Paul van Basten, Inge van Oort","doi":"10.1007/s13629-024-00419-3","DOIUrl":"https://doi.org/10.1007/s13629-024-00419-3","url":null,"abstract":"","PeriodicalId":38523,"journal":{"name":"Tijdschrift voor Urologie","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140422687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-11DOI: 10.1007/s13629-023-00415-z
Sanne L. Jansen, Jaap D. Legemate, Annemarie M. Leliveld, Laetitia M. O. de Kort
{"title":"Use of medical consumables in urology practice: is there a more sustainable way?","authors":"Sanne L. Jansen, Jaap D. Legemate, Annemarie M. Leliveld, Laetitia M. O. de Kort","doi":"10.1007/s13629-023-00415-z","DOIUrl":"https://doi.org/10.1007/s13629-023-00415-z","url":null,"abstract":"","PeriodicalId":38523,"journal":{"name":"Tijdschrift voor Urologie","volume":"8 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138979133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-11DOI: 10.1007/s13629-023-00414-0
Timo Michiels, A. Niemeijer, Jaap G. H. Poerink
{"title":"Shorter operative time independent of stone density with thulium fiber laser versus Holmium:YAG-laser","authors":"Timo Michiels, A. Niemeijer, Jaap G. H. Poerink","doi":"10.1007/s13629-023-00414-0","DOIUrl":"https://doi.org/10.1007/s13629-023-00414-0","url":null,"abstract":"","PeriodicalId":38523,"journal":{"name":"Tijdschrift voor Urologie","volume":"19 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139010657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01DOI: 10.1007/s13629-023-00411-3
Philip P. Oldenburg, K. T. Buddingh, Marleen M. van Dijk, Tim Verhaaf
{"title":"Stent-on-string. Evaluatie van het vernieuwde protocol in het HagaZiekenhuis","authors":"Philip P. Oldenburg, K. T. Buddingh, Marleen M. van Dijk, Tim Verhaaf","doi":"10.1007/s13629-023-00411-3","DOIUrl":"https://doi.org/10.1007/s13629-023-00411-3","url":null,"abstract":"","PeriodicalId":38523,"journal":{"name":"Tijdschrift voor Urologie","volume":"31 1","pages":"176 - 183"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138624800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-13DOI: 10.1007/s13629-023-00409-x
Noor van Ginkel, André N. Vis, Joost L. Boormans, Henk G. van der Poel, Deric K. E. van der Schoot, Katja K. H. Aben, Tom J. N. Hermans, Dennie Meijer, Jens Voortman, Tom J. H. Arends, Peter J. Ausems, Dorine Baselmans, Christian P. A. M. Berger, Anne-Claire Berrens, Henry Bickerstaffe, Siebe D. Bos, Marlene Braam, K. Tim Buddingh, Sebastiaan Claus, Karen Dekker, Thomas van Doeveren, Sarah M. H. Einerhand, Laurent M. C. Laurent Fossion, Florentien J. Hinsenveld, Erik J. van Gennep, Lorena A. Grondhuis Palacios, Mandy M. Hobijn, Suzanne H. van Huystee, Martinique Jaspers-Valentijn, O. Sjoerd Klaver, Evert L. Koldewijn, Linn Korsten, Anne Lenting, Koen J. Lentjes, Henk B. Luiting, Saskia van der Meer, Laura Mertens, Jakko A. Nieuwenhuijzen, M. Arjen Noordzij, Ronald I. Nooter, Marije Notenboom, Robert J. A. Oomen, Joep G. H. van Roermund, Judith de Rooij, Hossain Roshani, Bart P. Schrier, Michelle A. van der Slot, D. M. Rik Somford, Piter-Jan Stelwagen, Aukje M. A. Stroux, Alwine van der West, Bart P. Wijsman, Willemijn A. K. M. Windt, Paul van Zanten, Sytse C. van Beek
Samenvatting Er is onvoldoende bekend over de middellangetermijnoverleving van niet-gemetastaseerd spierinvasieve blaaskanker (SIBC) na open (ORC) versus robotgeassisteerde (RARC) cystectomie, met of zonder neoadjuvante chemotherapie (NAC). Om de vijfjaarsoverleving na beide interventies en de invloed van NAC te onderzoeken, is een retrospectieve studie verricht in 19 Nederlandse ziekenhuizen tussen 2012 en 2015. Van de totaal 1.534 cT1-4N0-1-patiënten ondergingen 1.086 patiënten een ORC en 389 een RARC. De vijfjaarsoverleving was 51% na ORC (95%-BI 47–53) versus 58% na RARC (95%-BI 52–63); de hazard ratio na multivariabele correctie was 1,00 (95%-BI 0,84–1,20). 226 van de 965 cT2-4aN0-patiënten werden behandeld met NAC. Na case-control matching bleek (y)pT0 vaker voor te komen na NAC dan zonder NAC (31 vs. 15%; p < 0,01). De beste vijfjaarsoverleving trad op bij patiënten met ypT0 na NAC, namelijk 89% (95%-BI 81–97). Concluderend laat deze deze studie bij patiënten met SIBC vergelijkbare vijfjaarsoverleving zien na ORC of na RARC. De beste overleving was bij patiënten die waren behandeld met NAC voorafgaand aan cystectomie.
{"title":"Intermediate term survival following open versus robot-assisted radical cystectomy in the Netherlands: results of the Cystectomie SNAPSHOT study","authors":"Noor van Ginkel, André N. Vis, Joost L. Boormans, Henk G. van der Poel, Deric K. E. van der Schoot, Katja K. H. Aben, Tom J. N. Hermans, Dennie Meijer, Jens Voortman, Tom J. H. Arends, Peter J. Ausems, Dorine Baselmans, Christian P. A. M. Berger, Anne-Claire Berrens, Henry Bickerstaffe, Siebe D. Bos, Marlene Braam, K. Tim Buddingh, Sebastiaan Claus, Karen Dekker, Thomas van Doeveren, Sarah M. H. Einerhand, Laurent M. C. Laurent Fossion, Florentien J. Hinsenveld, Erik J. van Gennep, Lorena A. Grondhuis Palacios, Mandy M. Hobijn, Suzanne H. van Huystee, Martinique Jaspers-Valentijn, O. Sjoerd Klaver, Evert L. Koldewijn, Linn Korsten, Anne Lenting, Koen J. Lentjes, Henk B. Luiting, Saskia van der Meer, Laura Mertens, Jakko A. Nieuwenhuijzen, M. Arjen Noordzij, Ronald I. Nooter, Marije Notenboom, Robert J. A. Oomen, Joep G. H. van Roermund, Judith de Rooij, Hossain Roshani, Bart P. Schrier, Michelle A. van der Slot, D. M. Rik Somford, Piter-Jan Stelwagen, Aukje M. A. Stroux, Alwine van der West, Bart P. Wijsman, Willemijn A. K. M. Windt, Paul van Zanten, Sytse C. van Beek","doi":"10.1007/s13629-023-00409-x","DOIUrl":"https://doi.org/10.1007/s13629-023-00409-x","url":null,"abstract":"Samenvatting Er is onvoldoende bekend over de middellangetermijnoverleving van niet-gemetastaseerd spierinvasieve blaaskanker (SIBC) na open (ORC) versus robotgeassisteerde (RARC) cystectomie, met of zonder neoadjuvante chemotherapie (NAC). Om de vijfjaarsoverleving na beide interventies en de invloed van NAC te onderzoeken, is een retrospectieve studie verricht in 19 Nederlandse ziekenhuizen tussen 2012 en 2015. Van de totaal 1.534 cT1-4N0-1-patiënten ondergingen 1.086 patiënten een ORC en 389 een RARC. De vijfjaarsoverleving was 51% na ORC (95%-BI 47–53) versus 58% na RARC (95%-BI 52–63); de hazard ratio na multivariabele correctie was 1,00 (95%-BI 0,84–1,20). 226 van de 965 cT2-4aN0-patiënten werden behandeld met NAC. Na case-control matching bleek (y)pT0 vaker voor te komen na NAC dan zonder NAC (31 vs. 15%; p < 0,01). De beste vijfjaarsoverleving trad op bij patiënten met ypT0 na NAC, namelijk 89% (95%-BI 81–97). Concluderend laat deze deze studie bij patiënten met SIBC vergelijkbare vijfjaarsoverleving zien na ORC of na RARC. De beste overleving was bij patiënten die waren behandeld met NAC voorafgaand aan cystectomie.","PeriodicalId":38523,"journal":{"name":"Tijdschrift voor Urologie","volume":"29 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136281533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-06DOI: 10.1007/s13629-023-00412-2
Henk G. van der Poel
{"title":"De cystectomie, nog steeds bewerkelijk, maar wel hoopgevende resultaten","authors":"Henk G. van der Poel","doi":"10.1007/s13629-023-00412-2","DOIUrl":"https://doi.org/10.1007/s13629-023-00412-2","url":null,"abstract":"","PeriodicalId":38523,"journal":{"name":"Tijdschrift voor Urologie","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135679280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：